The pharmaceutical company Johnson & Johnson (J&J) has announced this Thursday the withdrawal of its talcum powder for babies from the world market after accusations that the product causes cancer.
In a brief statement, the company has detailed that the ‘Johnson’s Baby Powder’ product will no longer be sold worldwide from 2023, while announcing the transition of the entire range of talcum powder products for babies so that they have a composition based on cornstarch. “We continually evaluate and optimize our portfolio to better position the business for long-term growth. This transition will help simplify our product offerings, deliver sustainable innovation and meet the needs of our consumers,” the pharmaceutical company said in the letter. Still, J&J has maintained its position on the safety of its cosmetic talcum powder, maintaining that it does not contain asbestos and does not cause cancer, as thousands of Americans have been complaining to the company.
In 2017, a Los Angeles court sentenced the pharmaceutical company to pay up to 417 million dollars (354 million euros at the time) considering that the group was responsible for terminal ovarian cancer diagnosed in a 63-year-old woman.
Likewise, the company was condemned for not adequately warning of the risk associated with the use of its products with talc, as reported at the time by the Los Angeles Times.